$Centessa Pharmaceuticals(CNTA.US)$Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares Dow Jones· 15 mins ago Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...
$Centessa Pharmaceuticals(CNTA.US)$The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy
$Centessa Pharmaceuticals(CNTA.US)$BOSTON and LONDON, Dec. 10, 2023 (GLOBE NEWSWIRE) --Centessa Pharmaceuticals plc(NASDAQ:CNTA), today announced new data from an additional 52-weeks of continuous treatment from the third year (Part 5) of the ongoing Phase 2a study of SerpinPC for the treatment of hemophilia. The data were shared in a poster presentation at the American Society of Hematology (ASH) Annual Meeting on Sunday, December 10, 2023. SerpinPC is an investigational subcutaneously...
$Centessa Pharmaceuticals(CNTA.US)$and$Schrodinger(SDGR.US)$will collaborate to discover therapies targeting the Orexin-2 receptor for sleep disorders. The agreement will give Centessa subsidiary Orexia Therapeutics access to Schrodinger's computing platform. The platform allows for high performance computing in order to accurately predict the effectiveness of the target of interest. The terms require Orexia to handle preclinical research activities, clinical development, and commercialization of potential candidates.
Jaguar8 : 一個大聲
Trytosaveabit樓主 Jaguar8: 不像我想的那麼糟糕!
Jaguar8 Trytosaveabit樓主: CYN 很糟糕哈哈
Trytosaveabit樓主 Jaguar8: 是的!嘿河
Jaguar8 Trytosaveabit樓主: 我相信很多人都被困擾,最終被背包。擴展是關鍵
查看更多評論...